Jennifer Mnookin Chancellor | Official website
Jennifer Mnookin Chancellor | Official website
James Dahlberg, a professor emeritus at the University of Wisconsin–Madison, has been recognized with the American Innovator Award by the Bayh-Dole Coalition. This accolade highlights his contributions to advancing federally funded inventions from research labs to practical applications.
Dahlberg's work has been instrumental in developing at-home health screenings, notably the Cologuard test for early colon cancer detection. His collaboration with UW–Madison and partnerships with entities like the Wisconsin Alumni Research Foundation (WARF) and chemistry professor Lloyd Smith led to significant advancements in biotechnology.
Erik Iverson, CEO of WARF, expressed admiration for Dahlberg's achievements: “WARF is delighted to celebrate Dr. Dahlberg for this well-deserved honor. His remarkable scientific expertise and dedication to bringing his technology to market have played a crucial role in Wisconsin’s emergence as a rapidly growing biohealth tech hub.”
Dahlberg joined UW–Madison in 1969 and made notable discoveries while studying DNA molecules. His findings led to innovations such as Cleavase, an enzyme that aids in detecting genetic differences critical for identifying cancer variants. This innovation paved the way for companies like Third Wave Technologies and Exact Sciences to develop diagnostic tools including tests for human papillomavirus (HPV) and colon cancer screening.
Joseph P. Allen of the Bayh-Dole Coalition emphasized Dahlberg's impact: “Dr. Dahlberg’s story underscores the importance of the Bayh-Dole Act, which enabled him to transform his research into a practical solution by launching his own startup.”
The Bayh-Dole Act allows universities and organizations to leverage federally funded research into consumer products, contributing significantly to economic growth and scientific progress.
In addition to founding Cambridge BioTech Corporation, Dahlberg holds 37 patents globally and has served in various advisory roles including interim director of the Morgridge Institute for Research.
Dorota Brzezinska from UW–Madison remarked on his legacy: “Dr. Dahlberg followed basic research down a path that led to discovery and delivered on the promise preserved in the Wisconsin Idea — to improve lives beyond the university’s borders.”
Research at UW–Madison continues its tradition of driving innovation and supporting industries vital for competitiveness and security across America.